Influence of Cytokines and Autologous Lymphokine-Activated Killer Cells on Leukemic Bone Marrow Cells and Colonies in AML

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 209-221

Karger

Access to resources Recommend Favorite

Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma

By  

Oncology, Vol. 84, Iss. 2, 2012-12 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

A Literature Analysis of Prognostic Factors for Response and Quality of Response of Patients with Renal Cell Carcinoma to Interleukin-2-Based Therapy

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 91-101

Karger

Access to resources Recommend Favorite

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4

By Kogure Toshiaki   Fujinaga Hiroshi   Niizawa Atsushi   Hai Le Xuan   Shimada Yutaka   Ochiai Hiroshi   Terasawa Katsutoshi  

Mediators of Inflammation, Vol. 8, Iss. 6, 1999-12 ,pp. : 313-318

Informa Healthcare

Access to resources Recommend Favorite

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human

By Kogure Toshiaki   Mantani Naoki   Goto Hirozo   Shimada Yutaka   Tamura Jun'ichi   Terasawa Katsutoshi  

Mediators of Inflammation, Vol. 11, Iss. 4, 2002-08 ,pp. : 219-224

Informa Healthcare

Access to resources Recommend Favorite